Back | Next |
home / stock / lpcn / lpcn message board
Subject | By | Source | When |
---|---|---|---|
It's going to be a win win. | gi197845 | investorshub | 07/21/2021 8:16:15 PM |
Do'h! | gi197845 | investorshub | 07/15/2021 3:43:24 PM |
Actually things look pretty darn good! Lawsuit aside, | Vance | investorshub | 06/08/2021 6:25:36 PM |
Yes, things don't look good for Lipocine or | gi197845 | investorshub | 05/26/2021 3:16:38 PM |
https://ih.advfn.com/stock-market/NASDAQ/lipocine-$LPCN/stock-news/85206412/claru | Rapier1911 | investorshub | 05/26/2021 12:03:57 PM |
Quite the range today, 1.25 to 1.56. | gi197845 | investorshub | 05/11/2021 4:22:17 PM |
Correction, huge volume today. | gi197845 | investorshub | 05/11/2021 2:30:40 PM |
Wow, big volume today. | gi197845 | investorshub | 05/11/2021 2:11:45 PM |
Not yet | Vance | investorshub | 05/06/2021 9:34:46 PM |
Is there a date for the Clarus court case? | BesaoT35 | investorshub | 05/06/2021 8:54:15 PM |
Do'h @ 1.38 now... | gi197845 | investorshub | 05/05/2021 6:45:07 PM |
Are you still long on $LPCN? | Vance | investorshub | 04/30/2021 1:59:05 AM |
I wonder what the results of the court | gi197845 | investorshub | 04/20/2021 5:40:55 PM |
It's a pretty substantial drop from 1.47 to | gi197845 | investorshub | 04/19/2021 4:47:42 PM |
Thanks Vance, thus far I think it's been | gi197845 | investorshub | 04/15/2021 9:37:33 PM |
You really ought to sell any shares you | Vance | investorshub | 04/14/2021 3:43:32 PM |
Before or after the r/s and dilution? | gi197845 | investorshub | 04/14/2021 4:08:36 AM |
Ok, thanks Vance. | gi197845 | investorshub | 04/12/2021 3:16:32 PM |
Yep, I'm Sure! There is No RS up | Vance | investorshub | 04/12/2021 3:48:15 AM |
Hi Vance, are you sure? | gi197845 | investorshub | 04/12/2021 3:46:07 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 02:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study PR Newswire Met standard bioequivalence (BE) criteria C max, AUC 0-t , and AUC 0- ∞ C trough criterion was met LPCN 1154 was well tolerat...
Shares of Lipocine Inc. (NASDAQ: LPCN) traded at a new 52-week high today and are currently trading at $8.96. So far today, approximately 78,318 shares have been exchanged, as compared to an average 30-day volume of 32,701 shares. Lipocine Inc., a clinical-stage biopharmaceutical company, foc...